|
|
Post by notamnkdmillionaire on Aug 7, 2015 17:03:12 GMT -5
FWIW, the Aug 17th edition of Time magazine does not have the Afrezza ad in it. Nor did it have the Toujeo ad in it.
|
|
|
|
Post by charlespk on Aug 7, 2015 18:57:39 GMT -5
Thanks for the info.
It is time to start the DTC ads on TV .
I talked to two individuals with diabetes yesterday . One was a type 2 , diagnosis was made when his blood glucose was in the 400's .
his wife told me his Hb Aic was > 9.
He said he had been on Metformin for several months , and his PCP had added Januvia , but recently his blood glucose was over 200 despite been on both , he had never heard of Afrezza .
I only gave him the name of Afrezza and asked him to google it , so he could ask his PCP , I also added that his PCP could be aware or not of this medication as it was relatively new.
The other person , I talked to surprised me even more as she told me her husband was a diabetic , ( type 2) , obese , and he was not in good control , her husband is an MD and had never heard of Afrezza, per his wife.
The message to me was loud and clear , until TV ads begin diabetic patients will not hear about Afrezza, so they can start on their own to ask their physicians .
I hope someone in the board can e-mail this comment to Matt , and please don't answer me with " Matt will tell you to call Sanofi . It is time for Mannkind to be proactive and defend its insulin , and show us the shareholders how they are protecting our shareholder value.
PS. I believe in Afrezza.
|
|
|
|
Post by mssciguy on Aug 7, 2015 19:19:51 GMT -5
FWIW, the Aug 17th edition of Time magazine does not have the Afrezza ad in it. Nor did it have the Toujeo ad in it. was it supposed to? This is not Breaking Bad... this is very advanced medical care  BTW, love your photo, loved that show |
|
|
|
Post by notamnkdmillionaire on Aug 7, 2015 20:09:59 GMT -5
FWIW, the Aug 17th edition of Time magazine does not have the Afrezza ad in it. Nor did it have the Toujeo ad in it. was it supposed to? This is not Breaking Bad... this is very advanced medical care BTW, love your photo, loved that show No. Just reporting it. It could be that the ad will run in the first issue of the month. At least I hope that is what they are intending to do. |
|
|
|
Post by notamnkdmillionaire on Aug 7, 2015 20:15:50 GMT -5
Thanks for the info.
It is time to start the DTC ads on TV .
I talked to two individuals with diabetes yesterday . One was a type 2 , diagnosis was made when his blood glucose was in the 400's .
his wife told me his Hb Aic was > 9.
He said he had been on Metformin for several months , and his PCP had added Januvia , but recently his blood glucose was over 200 despite been on both , he had never heard of Afrezza .
I only gave him the name of Afrezza and asked him to google it , so he could ask his PCP , I also added that his PCP could be aware or not of this medication as it was relatively new.
The other person , I talked to surprised me even more as she told me her husband was a diabetic , ( type 2) , obese , and he was not in good control , her husband is an MD and had never heard of Afrezza, per his wife.
The message to me was loud and clear , until TV ads begin diabetic patients will not hear about Afrezza, so they can start on their own to ask their physicians .
I hope someone in the board can e-mail this comment to Matt , and please don't answer me with " Matt will tell you to call Sanofi . It is time for Mannkind to be proactive and defend its insulin , and show us the shareholders how they are protecting our shareholder value.
PS. I believe in Afrezza.
I am not sold that Tv ads are going to be any helpful. It's hit and miss and god awfully expensive to run ads. The key is insurance and docs getting the full run down and education. I am going to hang my hat on the strategy that Sanofi is doing the controlled roll out to gather data that can be used. Cold hard data showing lower A1Cs, less hypos and better control than anything else out there is what is going to turn docs and insurance companies to push it, imo. But that is going to take time. Now we know why SNY is lending MNKD 175 million (or what ever the amount is) to help with the losses. We all had hoped this would be further along but SNY knows what they are doing contrary to what many arm chair posters (not in reference to you) are chirping about. |
|
|
|
Post by charlespk on Aug 9, 2015 14:31:08 GMT -5
mnkdmillionare
i respect your post and your points are right on.
i believe that to promote Afrezza there has to be a three prong approach , getting a better tier status by the insurance companies, education of physicians , and DTC ads
the first one I mention just like u did is of paramount importance, as without it , even if physicians are on board, and patients demand it , if they cannot afford it or they all require prior authorization, it will frustrate both physicians and patients, and the medication will never get traction
i see the issue as the proverbial Catch -22 , if patients don't know about it , they will not pose the question to their physician , if physicians are not well versed about it , they will be hesitant to prescribe it
insurance companies are not going to rush to give them a preferred status unless they feel the pressure from physicians and patients
timing of each of the above mentioned legs of the three prong is the key part
but in this day and and age ads do play a role to initiate the cascade while SNY keeps working on the insurance industry and the physicians
|
|
|
|
Post by orlon on Aug 9, 2015 16:03:10 GMT -5
mnkdmillionare i respect your post and your points are right on. i believe that to promote Afrezza there has to be a three prong approach , getting a better tier status by the insurance companies, education of physicians , and DTC ads the first one I mention just like u did is of paramount importance, as without it , even if physicians are on board, and patients demand it , if they cannot afford it or they all require prior authorization, it will frustrate both physicians and patients, and the medication will never get traction i see the issue as the proverbial Catch -22 , if patients don't know about it , they will not pose the question to their physician , if physicians are not well versed about it , they will be hesitant to prescribe it insurance companies are not going to rush to give them a preferred status unless they feel the pressure from physicians and patients timing of each of the above mentioned legs of the three prong is the key part but in this day and and age ads do play a role to initiate the cascade while SNY keeps working on the insurance industry and the physicians I agree. With all the drugs pushed on TV addressing erectile dysfunction, constipation, diarrhea, headaches and backaches, each ends with, "Ask your Dr. if....I think a well produced AFREZZA TV ad touting the benefits of inhaled insulin, and ending with, "Ask your Doctor if AFREZZA is right for you," would do wonders. |
|
|
|
Post by peppy on Aug 9, 2015 16:22:34 GMT -5
mnkdmillionare i respect your post and your points are right on. i believe that to promote Afrezza there has to be a three prong approach , getting a better tier status by the insurance companies, education of physicians , and DTC ads the first one I mention just like u did is of paramount importance, as without it , even if physicians are on board, and patients demand it , if they cannot afford it or they all require prior authorization, it will frustrate both physicians and patients, and the medication will never get traction i see the issue as the proverbial Catch -22 , if patients don't know about it , they will not pose the question to their physician , if physicians are not well versed about it , they will be hesitant to prescribe it insurance companies are not going to rush to give them a preferred status unless they feel the pressure from physicians and patients timing of each of the above mentioned legs of the three prong is the key part but in this day and and age ads do play a role to initiate the cascade while SNY keeps working on the insurance industry and the physicians I agree. With all the drugs pushed on TV addressing erectile dysfunction, constipation, diarrhea, headaches and backaches, each ends with, "Ask your Dr. if....I think a well produced AFREZZA TV ad touting the benefits of inhaled insulin, and ending with, "Ask your Doctor if AFREZZA is right for you," would do wonders. The quote, "never bite the hand that feeds you" has been playing over and over in my mind. Sanofi: may not be able to start the DTC adds yet with the ending, "Ask your Doctor if Afrezza is right for you." The doctors do not know about it.
This was posted under another link today. 29 million w diabetes in U.S. Only 18400 CDEs (1 per 1581 PWD) and 4000 endocrinologists (1per 7,275 PWD). Wow.
if 4000 endocrinologist is correct.... how many family practice? The adds run, people call the office, the physicians do not know about the drug... Does that make the physician look bad?
|
|
|
|
Post by sportsrancho on Aug 9, 2015 17:57:16 GMT -5
I have yet to meet one diabetic who knows about Afrezza. (With out me telling them.) I talked to two this week. One has insurance with the VA and can't get a appointment for two months. She is an older T2 and over weight. She had planed to ask her doctor for Farxiga. I asked her where she heard about that? After I told her all the bad side affects! TV! It's on all the time and they are all talking about it:-( You know the ad... with all the happy people dancing around. I don't presume to know when the right time is for TV. But it will make a big difference!!!
|
|
|
|
Post by BlueCat on Aug 9, 2015 18:58:09 GMT -5
Agree it will make a difference. But it is costly and I think the prep work of getting the doctors to know about it, getting it considered 'reasonably' priced, and having the production capacity to meet demand is still important.
That said - you don't wait until all of that is 100% solved. Just close enough for success. What percentage of docs need to be in the know, how much stockpile, how long they project increase in demand due to spots - SNY would already have estimations on all of this. Not their first rodeo.
But when its ready. Yea. They should run some ads. Biggest issue is "AWARENESS". Even better if they can cite (assuming studies complete) that it has the potential to reverse some early TII symptoms ….. SIZZLE.
|
|
|
|
Post by thekindaguyiyam on Aug 10, 2015 10:12:59 GMT -5
FWIW, the Aug 17th edition of Time magazine does not have the Afrezza ad in it. Nor did it have the Toujeo ad in it. Magazines get distributed to specific parts of the country with different advertising content. You've seen email sent to you with your name on it and your name incorporated into the body of a message seemingly designed for you. That's the way they market. What sells in Alabama is unlikely to be the same market in pennsylvania. Target marketing within the magazine distribution is used as a test to see if that market is successful and worth moving into other markets. Likewise; just like other advertising, the message must be dynamic and well defined within a 2-4 second view to capture attention. Unlike a radio spot or TV ad ... it's the timing of being there at that moment to catch the advertisement while a magazine holds that advertisement in place on someones table or in their office for multiple people to view. This is the way it works. On assignment I was given the task to get into phillip morris to see the advertisment they placed in a magazine to solicit teenagers to smoke by using a subject that they were studying in class... It was impossible to communicate with the company to ask for verification as it was locked up tight. Calling public libraries in the area of distribution confirmed the ad placement even though the same ad was not replicated in other parts of the US. In close. Just because an Ad for Afrezza shows up somewhere doesn't mean that it will be nationally distributed in all target markets. FWIW |
|
|
|
Post by otherottawaguy on Aug 10, 2015 10:36:24 GMT -5
Saw the ad in Aug 3 Time magazine here in Ottawa Canada last week. Numerous US magazines have a Canadian version with differentiated adverts so was pleasantly surprised to see the add. Looked to be the same one pager that was in the diabetes mag last month.
As a side note, don't think Toujero is avail here in the "Great White North" but the ad was also in the Time as well.
|
|
|
|
Post by notamnkdmillionaire on Aug 10, 2015 10:43:00 GMT -5
FWIW, the Aug 17th edition of Time magazine does not have the Afrezza ad in it. Nor did it have the Toujeo ad in it. Magazines get distributed to specific parts of the country with different advertising content. You've seen email sent to you with your name on it and your name incorporated into the body of a message seemingly designed for you. That's the way they market. What sells in Alabama is unlikely to be the same market in pennsylvania. Target marketing within the magazine distribution is used as a test to see if that market is successful and worth moving into other markets. Likewise; just like other advertising, the message must be dynamic and well defined within a 2-4 second view to capture attention. Unlike a radio spot or TV ad ... it's the timing of being there at that moment to catch the advertisement while a magazine holds that advertisement in place on someones table or in their office for multiple people to view. This is the way it works. On assignment I was given the task to get into phillip morris to see the advertisment they placed in a magazine to solicit teenagers to smoke by using a subject that they were studying in class... It was impossible to communicate with the company to ask for verification as it was locked up tight. Calling public libraries in the area of distribution confirmed the ad placement even though the same ad was not replicated in other parts of the US. In close. Just because an Ad for Afrezza shows up somewhere doesn't mean that it will be nationally distributed in all target markets. FWIW I understand. The person that gets Time magazine in the complex I live in is what I am sourcing as to where I have seen the ad. The Aug 3rd editions had it. The one that just came for the week of Aug 17th didn't have either the Aferzza or the Toujeo ad. My guess is that Sanofi isn't publishing the ads in every subscription and might be using the first magazine of the month to place the ad. Btw, Time magazine has VERY few ads in it to begin with. And I also live in one of the most populated cities in the country. This is one place you aren't going to neglect if you want to sell a drug. |
|
|
|
Post by thekindaguyiyam on Aug 10, 2015 10:55:43 GMT -5
Mnkdmillionaire
You said: "This is one place you aren't going to neglect if you want to sell a drug."
My reply would be... no doubt about it regarding marketing to populated cities will continue to be an essential focus. The question is; how effective that advertising was in it's distribution and if it was successful enough to warrant more advertising with the financial topic being filed under "how much bang for the buck" did the advertising result in personal interest that influence buying the product.
Print advertising is going the way of the dinosaur. It's expensive. The news is old by the time you get the magazine. There are many ways to approach marketing as you well know. Whoever is in charge of making these decisions no doubt has years of experience in marketing other drugs for Sanofi. I personally don't read magazines anymore. I find the news faster and more specific on the internet. There will be many methods to get the word out; I'm just explaining the target marketing platform of regional distribution in selected markets for trial.
I enjoy reading your posts... keep them coming.
|
|
|
|
Post by notamnkdmillionaire on Aug 10, 2015 11:18:55 GMT -5
Mnkdmillionaire You said: "This is one place you aren't going to neglect if you want to sell a drug." My reply would be... no doubt about it regarding marketing to populated cities will continue to be an essential focus. The question is; how effective that advertising was in it's distribution and if it was successful enough to warrant more advertising with the financial topic being filed under "how much bang for the buck" did the advertising result in personal interest that influence buying the product. Print advertising is going the way of the dinosaur. It's expensive. The news is old by the time you get the magazine. There are many ways to approach marketing as you well know. Whoever is in charge of making these decisions no doubt has years of experience in marketing other drugs for Sanofi. I personally don't read magazines anymore. I find the news faster and more specific on the internet. There will be many methods to get the word out; I'm just explaining the target marketing platform of regional distribution in selected markets for trial. I enjoy reading your posts... keep them coming. Thanks. One final thought. All the advertising in the world isn't going to do squat if 1) Doctors are clueless on the drug 2) Sanofi isn't making the effort to get reps to educate docs 3) Most importantly, Insurance companies still hamstringing Afrezza by not covering or limiting the coverage of it. |
|
